Articles published by Ocugen
Ocugen to Present at Investing in Cures Summit
March 06, 2024
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen Clinical Showcase Webcast Now Available
February 28, 2024
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen to Present at 2024 BIO CEO & Investor Conference
February 21, 2024
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen to Present at Pharma Market Research Conference
January 31, 2024
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
January 16, 2024
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
December 21, 2023
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
November 29, 2023
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
October 10, 2023
From Ocugen
Via GlobeNewswire
Tickers
OCGN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.